Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.31 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24608701 | 0.86 | NOX1 (0.34) | BCHENOX1 | |
| SCHEMBL24569263 | 0.85 | NOX1 (0.36) | BCHEMEN1KMT2AALDH1A1NOX1 | |
| SCHEMBL24608611 | 0.85 | NPC1 (0.39) | ALDH1A1 | |
| SCHEMBL24608745 | 0.85 | ELANE (0.38) | ELANEMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL24569268 | 0.84 | MEN1 (0.33) | BCHEMEN1KMT2AHTTATM | |
| SCHEMBL24608894 | 0.83 | ELANE (0.37) | ELANEMEN1KMT2AHTTMAPT | |
| SCHEMBL24608709 | 0.81 | — | — | |
| SCHEMBL24608641 | 0.80 | TYMS (0.35) | BCHE | |
| SCHEMBL24608706 | 0.79 | BCHE (0.42) | BCHEMEN1HPGDKMT2AKDM4E | |
| SCHEMBL27105015 | 0.79 | NPC1 (0.39) | BCHEMEN1HPGDKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11917912-B2 | Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source | CANON KABUSHIKI KAISHA (JP) | 2024-02-27 | — | — | US | disclosed |
| US-11917912-B2 | Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source | CANON KABUSHIKI KAISHA (JP) | 2024-02-27 | — | — | US | disclosed |
| US-20220216423-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE | CANON KABUSHIKI KAISHA (JP) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11917912-B2 | Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source | AOX1, SOD1, L1CAM | ELANE 757/4885BCHE 2209/4885MEN1 2311/4885 |
| US-20220216423-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE | AOX1, SOD1, L1CAM | ELANE 757/4885BCHE 2209/4885MEN1 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.